PVC-induced cardiomyopathy is a weakening of the heart muscle that can happen when extra heartbeats called premature ventricular contractions (PVCs) occur very often over time. These extra beats can make the heart pump less effectively. Many people with PVCs never develop this problem. Doctors look at the heart rhythm, how often PVCs occur, and heart scans to judge whether they may be causing reduced pumping strength.
How can frequent PVCs weaken the heart?
Premature ventricular contractions are extra heartbeats that begin in the heart's lower chambers, called the ventricles. They occur earlier than expected in the normal heartbeat and may feel like a skipped beat, a flutter, or a sudden thump in the chest. Occasional PVCs are common and usually do not cause lasting heart problems.
When PVCs occur frequently over a prolonged period, however, they can interfere with the heart's normal pumping function. The heart muscle may become weaker, and the left ventricle, which pumps oxygen-rich blood to the body, may no longer contract as effectively. This condition is called PVC-induced cardiomyopathy. According to the Cleveland Clinic, frequent PVCs can sometimes damage the heart muscle over time, even though most isolated PVCs are not dangerous.
The term PVC-induced means that frequent extra heartbeats are thought to be the cause of the heart muscle weakness. PVCs can also worsen cardiomyopathy that already exists for another reason. Distinguishing between these situations matters because reducing PVCs may improve heart function when the abnormal rhythm is contributing to the problem.
Does the number of PVCs determine the risk?
One important measurement is the PVC burden, which is the percentage of all heartbeats that are premature ventricular contractions during a monitoring period. A higher burden is associated with a greater risk of developing cardiomyopathy, but there is no single number that determines whether a person's heart will be affected.
The European Society of Cardiology (ESC) identifies a PVC burden of around 10% or more as an important threshold when considering PVC-induced cardiomyopathy. The risk may rise further when the burden exceeds 20%. These figures guide clinical assessment rather than establish a diagnosis: some people have frequent PVCs without impaired heart function, while others require further investigation to understand why their heart's pumping ability has declined.
Risk also depends on the wider clinical picture. PVCs can occur in people with otherwise healthy hearts and in people with an existing cardiac condition. Their frequency and pattern, the duration of the abnormal rhythm, and evidence of other heart muscle problems all help clinicians judge whether PVCs are likely to be responsible for reduced pumping function. The precise burden at which cardiomyopathy develops varies between individuals and remains an area of clinical research.
What symptoms can PVC-induced cardiomyopathy cause?
Some people have no noticeable symptoms, and frequent PVCs may be discovered during a routine heart test. Others experience palpitations from the extra beats or symptoms associated with reduced pumping function. Examples include:
- A fluttering, pounding, or skipped-beat sensation in the chest.
- Unusual tiredness or reduced energy during everyday activities.
- Shortness of breath, particularly during physical activity.
- Reduced exercise tolerance compared with usual activity levels.
- Dizziness or feeling lightheaded.
- Swelling in the feet or ankles when fluid builds up.
These experiences can have several causes and do not, by themselves, establish that PVCs have weakened the heart. Persistent or worsening palpitations, new breathlessness, unexplained fatigue, or a noticeable decline in exercise ability should be assessed by a healthcare professional.
How do doctors diagnose PVC-induced cardiomyopathy?
Diagnosis involves checking how often PVCs occur, assessing how well the heart pumps, and looking for other explanations for the findings. A healthcare professional considers the medical history, symptoms, examination, heart rhythm recordings, and imaging results together. PVC-induced cardiomyopathy is suspected when frequent PVCs occur alongside reduced heart function and other likely causes have been investigated.
Electrocardiogram and heart rhythm monitoring
An electrocardiogram (ECG or EKG) records the heart's electrical activity and can identify PVCs during the test. Because extra beats may not happen continuously, a short ECG may not show how frequently they occur throughout the day. A Holter monitor or another wearable rhythm monitor can record heartbeats over one or more days, helping clinicians calculate the PVC burden and assess the rhythm pattern.
Echocardiogram and cardiac MRI
An echocardiogram uses ultrasound to show the heart's structure and movement. It helps measure the left ventricular ejection fraction, or LVEF, which is the percentage of blood the left ventricle pumps out with each contraction. A reduced LVEF can indicate impaired pumping function, although the finding alone does not reveal its cause.
Cardiac magnetic resonance imaging (MRI) may be recommended when doctors need a closer assessment of the heart muscle or want to look for signs of scarring and other structural abnormalities. Blood tests and other cardiac investigations may also be appropriate when the history or initial test results suggest another possible cause. The American College of Cardiology summarizes guidance recommending consideration of cardiac MRI when PVC-induced cardiomyopathy is suspected, particularly when the cause of reduced pumping function is unclear.
What treatments can help restore heart function?
Treatment aims to reduce the PVCs when they are contributing to heart muscle weakness and to address any other heart condition that may be present. The choice depends on the PVC burden, the degree of ventricular dysfunction, symptoms, the location and pattern of the abnormal beats, other medical conditions, and the likely benefits and risks of each option.
Medication to control abnormal heartbeats
Medication may be used to reduce PVC frequency and, in selected patients, improve symptoms or heart function. Options can include beta-blockers and specific antiarrhythmic medicines. The most appropriate choice depends on the person's heart rhythm, cardiac function, other health conditions, and potential medication side effects. Some antiarrhythmic medicines require careful specialist supervision because they can cause significant adverse effects or affect other aspects of the heart's rhythm.
Catheter ablation
Catheter ablation is a procedure that targets the small area of heart tissue producing the abnormal electrical signals. A specialist guides thin tubes called catheters through blood vessels to the heart, identifies the source of the PVCs, and applies energy to prevent the unwanted signals from recurring.
According to the European Society of Cardiology, catheter ablation is recommended when cardiomyopathy is suspected to result from frequent, predominantly similar-looking PVCs. It can be particularly useful when medicines are ineffective, cause unacceptable side effects, or are not the preferred approach. Like any invasive procedure, ablation has potential risks, so a heart rhythm specialist discusses its suitability and expected benefits before proceeding.
Monitoring and treatment of reduced heart function
Not everyone with PVCs needs medication or ablation. When heart function is normal and the clinical assessment does not show a need for immediate intervention, periodic heart rhythm monitoring and repeat imaging may be appropriate. If cardiomyopathy is present, clinicians may also prescribe medicines specifically to support heart function or manage symptoms of heart failure. Correcting a contributing problem, such as an identified electrolyte imbalance, may be part of the overall plan.
Can the heart recover after PVC-induced cardiomyopathy?
In many cases, heart function improves when frequent PVCs are successfully reduced or eliminated. Recovery is possible because PVC-induced cardiomyopathy can be a reversible cause of weakened heart muscle. Improvement often occurs over weeks to months, although the pace and extent of recovery vary. Some people regain normal pumping function, while others have a partial improvement or continue to have reduced function because another heart condition is also present.
A review published in PubMed Central, maintained by the U.S. National Library of Medicine, describes improvement in ventricular function after successful suppression of frequent PVCs. In clinical practice, repeat rhythm monitoring and an echocardiogram help determine whether the PVC burden has fallen and whether the heart's pumping ability has improved. Follow-up remains important even when symptoms become less noticeable, because the absence of palpitations does not necessarily confirm that PVCs have stopped.
When should medical attention be sought?
Arrange a medical assessment for persistent or worsening palpitations, unexplained breathlessness, declining exercise tolerance, or new swelling of the feet or ankles. These symptoms deserve attention because they can occur with several heart conditions, including problems affecting the heart's pumping function.
Seek emergency medical care for chest pain, fainting, severe or sudden shortness of breath, or sudden confusion, particularly when these occur with an abnormal heartbeat. These symptoms can indicate a potentially serious problem and should not be assessed at home.
The central point is that frequent PVCs do not automatically mean that the heart muscle is weakening. When cardiomyopathy does develop, identifying whether PVCs are responsible or contributing to it can help clinicians choose an appropriate treatment and assess the potential for recovery.